Hicks RJ - Search Results

1

Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN).

Kong G, Grozinsky-Glasberg S, Hofman MS, Akhurst T, Meirovitz A, Maimon O, Krausz Y, Godefroy J, Michael M, Gross DJ, Hicks RJ. Kong G, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):718-727. doi: 10.1007/s00259-018-4196-8. Epub 2018 Oct 20. Eur J Nucl Med Mol Imaging. 2019. PMID: 30343432

2

Iodine-123 N-methyl-4-iododexetimide: a new radioligand for single-photon emission tomographic imaging of myocardial muscarinic receptors.

Hicks RJ, Kassiou M, Eu P, Katsifis AG, Garra M, Power J, Najdovski L, Lambrecht RM. Hicks RJ, et al. Eur J Nucl Med. 1995 Apr;22(4):339-45. doi: 10.1007/BF00941851. Eur J Nucl Med. 1995. PMID: 7607265

3

Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.

Kalff V, Hicks RJ, Ware RE, Greer B, Binns DS, Hogg A. Kalff V, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):506-15. doi: 10.1007/s00259-001-0735-8. Epub 2002 Feb 15. Eur J Nucl Med Mol Imaging. 2002. PMID: 11914889

4

The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.

Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. Kalff V, et al. Among authors: hicks rj. J Nucl Med. 2002 Apr;43(4):492-9. J Nucl Med. 2002. PMID: 11937593 Free article.

5

FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burden.

MacManus MR, Hicks R, Fisher R, Rischin D, Michael M, Wirth A, Ball DL. MacManus MR, et al. Acta Oncol. 2003;42(1):48-54. doi: 10.1080/0891060310002230. Acta Oncol. 2003. PMID: 12665331

6

Detection of synchronous adenocarcinomas and multiple dysplastic polyps with F-18 FDG positron emission tomography in a case of nonfamilial polyposis.

Patrikeos AP, Mackay JR, Hicks RJ. Patrikeos AP, et al. Among authors: hicks rj. Clin Nucl Med. 2003 Jun;28(6):487-8. doi: 10.1097/01.RLU.0000067510.43457.52. Clin Nucl Med. 2003. PMID: 12917531 No abstract available.

7

Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience.

Blum R, MacManus MP, Rischin D, Michael M, Ball D, Hicks RJ. Blum R, et al. Among authors: hicks rj. Am J Clin Oncol. 2004 Apr;27(2):164-71. doi: 10.1097/01.coc.0000054889.58718.6f. Am J Clin Oncol. 2004. PMID: 15057156

8

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.

Loi S, Ngan SY, Hicks RJ, Mukesh B, Mitchell P, Michael M, Zalcberg J, Leong T, Lim-Joon D, Mackay J, Rischin D. Loi S, et al. Among authors: hicks rj. Br J Cancer. 2005 Feb 28;92(4):655-61. doi: 10.1038/sj.bjc.6602413. Br J Cancer. 2005. PMID: 15700033 Free PMC article. Clinical Trial.

9

The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin.

Scott CL, Kudaba I, Stewart JM, Hicks RJ, Rischin D. Scott CL, et al. Among authors: hicks rj. Mol Imaging Biol. 2005 May-Jun;7(3):236-43. doi: 10.1007/s11307-005-4114-x. Mol Imaging Biol. 2005. PMID: 15912428

10

Initial staging of lymphoma with positron emission tomography and computed tomography.

Hicks RJ, Mac Manus MP, Seymour JF. Hicks RJ, et al. Semin Nucl Med. 2005 Jul;35(3):165-75. doi: 10.1053/j.semnuclmed.2005.02.003. Semin Nucl Med. 2005. PMID: 16098290 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters